FDA examination favors initial drug for HIV prevention

<p>WASHINGTON (AP) — A tablet that has prolonged been used to yield HIV has changed one step closer to apropos a initial drug authorized to forestall healthy people from apropos putrescent with a pathogen that causes AIDS.
The Food and Drug Administration pronounced Tuesday that Gilead Sciences Truvada appears to be stable and effective for HIV prevention. It resolved that holding a tablet daily could gangling patients infection with a critical and life-threatening illness that requires lifelong treatment.
On Thursday a row of FDA advisers will cruise a examination when it votes on either Truvada should be authorized as a medicine diagnosis for people who are during high risk of constrictive HIV by passionate intercourse. The FDA is not compulsory to follow a recommendation of a panels, though it customarily does.
An estimated 1.2 million Americans have HIV, that attacks a defence complement and, unless treated with antiviral drugs, develops into AIDS, a deadly condition in that ...